跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22,605 条关于
“Hanmi Pharmaceutical Co.”
全部
22,605
临床试验
3,147
药物
2,392
机构
3,220
资讯
13,846
去年
Hanmi Pharma Accelerates Launch of Efpeglenatide for Obesity Treatment
去年
Aptose Biosciences' Tuspetinib Shows Promise in AML Triplet Therapy, Receives $10M Loan from Hanmi
2年前
Hanmi Pharmaceutical Partners with MSD to Test Novel Bispecific Antibody BH3120 in Combination with KEYTRUDA
2年前
GC Biopharma and Hanmi Pharmaceutical's Fabry Disease Treatment LA-GLA Receives FDA IND Clearance
9个月前
Hanmi Pharmaceutical's Efeglenatide Receives Fast Track Designation for Obesity Treatment in South Korea
去年
Hanmi's BH3120 Shows Promise in Phase 1 Trials for Advanced Solid Tumors
去年
Hanmi's BH3120 Shows Promise in Early Clinical Trials for Advanced Solid Tumors
去年
Hanmi Pharmaceutical Advances BH3120 Immunotherapy Trials Targeting Solid Tumors
去年
Hanmi Pharmaceutical Fast-Tracks Efeglenatide Launch for Obesity Treatment
12天前
Hanmi Pharmaceutical to Fully Deploy AI Across Quality Assurance, Training on 4,000 SOPs
第 1 页,共 1385 页
上一页
下一页